|
Schizophrenia and Antipsychotic Treatment Stacy Weinberg
|
tarix | 14.01.2017 | ölçüsü | 1,14 Mb. | | #5361 |
|
Stacy Weinberg 3 April 2007
What is it?
Types Catatonic Type - Either in position or speech (imitating others)
- Very rare
Disorganized Type - Disturbance in behavior, speech, and thought
- Flat affect, eccentric
Paranoid Type - Delusions and auditory hallucinations
- Cognitive functioning remains intact
Residual Type - Have been previously diagnosed but no longer show prominent symptoms; still have other symptoms
Undifferentiated Type
Disturbances of thought processes Delusions Hallucinations Erratic/extreme emotions Very slow or fast movement, catatonia Behavioral changes
Negative Symptoms Lack of interest/enjoyment in activities Low energy/motivation Blank facial expression, less facial variability Difficulty initiating activities Social isolation
Causes - Dopamine Hypothesis Genetic aspect Most think it involves dopamine: - Elevation of D2 monomers, decrease of dimers
- Increased release of dopamine
- 2x higher
- When given amphetamine, 2x more
- dopamine is released than control
Dopamine hypothesis not agreed on by everyone Some think excitatory amino acids like glutamate could play a role - One type of glutamate receptor, NMDA: NMDA antagonists (ex ketamine) can induce psychotic symptoms in non-schizophrenic patients
- Found increase of NMDA receptors in postmortem studies of schizophrenic brains
Types of Drug Treatment Typical Antipsychotics Atypical Antipsychotics Combination Drugs
Typical Tend to produce Extrapyramidal side effects: - Parkinsonism – tremors, rigidity, slowness of movement, temporary paralysis
- Dystonia – involuntary muscle contractions
- Akathisia – inability to resist urge to move
- Tardive dyskinesia – involuntary movements of the mouth, lips, and tongue
- Chewing, puckering, grimacing, etc.
Typical - Phenothiazines Chlorpromazine first developed from promethazine, first tricyclic antihistamine
Haloperidol Butyrophenone Used in 1970s almost exclusively No anticholinergic effects – therefore used in patients with delirium
Atypicals Atypicals do not induce EPSE Block D2 receptors and 5-HT seratonin receptors (decreases EPSE) As opposed to typicals, these are more loosely bound to D2 receptors - Easier dissociation
- Shown that higher occupation of D2 receptors by drug, higher incidence of EPSE
5-HT seratonin receptors Blocking 5-HT seratonin receptors decreases negative symptoms and EPSE - Mechanism is unknown
- Seratonin inhibits dopamine release
- Positive symptoms associated with hyperdopaminergic condition in limbic lobe – more D2 receptors here, so D2 blocking prevails
- Negative symptoms associated with hypodopaminergic condition in frontal lobe – more 5-HT receptors here, so seratonin inhibits dopamine release – stabilizes dopamine level
Clozapine First atypical (1990) Most dangerous atypical: risk of agranulocytosis (severe decrease in WBC count) Most effective in reducing EPSE, also in reducing negative symptoms - Increases Fos-positive neurons in the prefrontal cortex (shown to affect negative symptoms)
Risperidone Low doses needed Predominantly blocks D2, then 5-HT - Does not exhibit multireceptor action
Lacks anticholinergic activity – makes it better for youth, elderly Problem – increases prolactin levels (shouldn’t give to people with breast cancer)
Olanzapine Zyprexa is number one antipsychotic in sales (Eli Lilly) Exhibits multireceptor action Good for controlling mood symptoms Available in a wafer weight gain
Combinations Example is Symbyax - Combination of olanzapine and fluoxetine (Prozac)
- Can also treat bipolar disorder
Combination of ziprasidone and clozapine - Can be used to combat treatment resistance
Combination of aripriprazole and clozapine
Dostları ilə paylaş: |
|
|